BIIB059, BIIB059 placebo is a sterile liquid for injection. The formulation composition of the placebo is identical to that of BIIB059 drug product minus the active ingredient
230LE303
Phase 3 small_molecule active
Quick answer
BIIB059, BIIB059 placebo is a sterile liquid for injection. The formulation composition of the placebo is identical to that of BIIB059 drug product minus the active ingredient for systemic lupus erythematosus is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- systemic lupus erythematosus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active